Evaluation of Prescriber Responses to Pharmacist Recommendations Communicated by Fax in a Medication Therapy Management Program (MTMP)

Abstract

BACKGROUND As defined by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, medication therapy management programs (MTMPs) must be designed to decrease adverse drug events and improve patient outcomes by promoting appropriate medication use. WellPoint Inc. contracted with the pharmacist-run University of Arizona College of Pharmacy Medication Management Center (UA MMC) to provide a pilot telephone-based MTMP to approximately 5,000 high-risk beneficiaries from among its nearly 2 million Medicare prescription drug plan (PDP) beneficiaries. Eligibility for the program was determined by a minimum of 2 of 6 chronic diseases (dyslipidemia, cardiovascular disease, depression, diabetes mellitus, congestive heart failure, and chronic obstructive pulmonary disease; at least 1 of the latter 2 diseases must be present), at least 3 Part-D covered medications, and greater than $4,000 per year in predicted drug spending. In addition to these criteria, WellPoint Inc. used the Johns Hopkins adjusted clinical groups (ACG) predictive model to identify the high-risk beneficiaries to be enrolled in the program. Medication therapy reviews were conducted for these patients. If any medication-related problems (MRPs) were identified, the patient’s prescribers were contacted via a fax communication with recommendation(s) to resolve these MRPs. The UA MMC fax interventions were categorized as cost saving, guideline adherence, or safety concerns. OBJECTIVES To (a) determine prescriber responses to pharmacist-initiated recommendations in an MTMP for the 3 intervention categories, (b) compare prescriber responses between intervention categories, and (c) compare prescriber response by prescriber type (primary care physician [PCP] vs. specialist) within each intervention category. METHODS A retrospective analysis of pharmacist-initiated interventions from August through December 2008 was performed using data collected from the UA MMC database. Data were collected on intervention category (cost saving, guideline adherence, or safety concerns), and responses of prescribers were recorded as either approval or decline (no response was considered decline). Prescriber specialty was identified from searching records of state medical boards. Logistic regression analyses with the robust variance option to adjust for correlation within prescribers were conducted to compare prescriber approval rates between and within intervention categories. Significance was assessed at alpha 0.05. RESULTS Of 4,967 Medicare Part D beneficiaries determined to be MTMP-eligible, 4,277 beneficiaries (86.1%) were available for assessment (400 declined, 186 disenrolled, and 104 were deceased). Pharmacists initiated 1,548 valid medication recommendations (i.e., recommendations were excluded for deceased patients, incorrect prescribers, and where prescriber specialty was not identified). These recommendations for 1,174 beneficiaries (27.5% of those available) were faxed to prescribers requesting approval. Mean (SD) age for beneficiaries having re...

Impact of a pharmacy technician-centered medication reconciliation program on medication discrepancies and implementation of recommendations

“…Classifying the pharmacist’s recommendations and the percentage of recommendations implemented by the prescriber during medication reconciliation is not well documented in literature. In this study only urgent recommendations were verbally communicated to prescribers and all other recommendations were documented in the EHR 15,16…”

Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population

“…Provider acceptance (65.79%) of pharmacist interventions, was higher than some rates previously reported [15][16][17]. Interestingly, Perera et al found that pharmacist-delivered provider interventions communicated via facsimile had reported lower provider acceptance rates, particularly those related to guideline adherence and safety concerns [17].…”

Medicare Part D Research and Policy Highlights, 2012: Impact and Insights

“…32 Other studies have evaluated MTM initiatives. Using 2008 telephone-based MTM data from a large PDP plan (n = 4277), Perera et al 33 reported that the rate of prescribers’ approval of pharmacists’ recommendations of drug therapy changes in MTM beneficiaries was 47.2% overall, with higher approval rates involving cost-saving issues and lower rates involving safety concerns and guideline adherence. Overall, primary care physicians had higher approval rates than did specialists.…”

“…More empirical evidence is needed to inform MTM best practices, including ways to promote pharmacist–prescriber collaborations. 33 …”